183 related articles for article (PubMed ID: 30077474)
1. YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines.
Umapathy D; Dornadula S; Krishnamoorthy E; Mariappanadar V; Viswanathan V; Ramkumar KM
Immunobiology; 2018 Nov; 223(11):718-727. PubMed ID: 30077474
[TBL] [Abstract][Full Text] [Related]
2. Correlation between serum YKL-40 levels and albuminuria in type 2 diabetes.
Han JY; Ma XY; Yu LJ; Shao Y; Wang QY
Genet Mol Res; 2015 Dec; 14(4):18596-603. PubMed ID: 26782508
[TBL] [Abstract][Full Text] [Related]
3. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
[TBL] [Abstract][Full Text] [Related]
4. Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients.
Lee JH; Kim SS; Kim IJ; Song SH; Kim YK; In Kim J; Jeon YK; Kim BH; Kwak IS
J Diabetes Complications; 2012; 26(4):308-12. PubMed ID: 22705282
[TBL] [Abstract][Full Text] [Related]
5. Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.
Suh JS; Kim SH; Cho KS; Jung IA; Cho WK; Jeon YJ; Jung MH; Suh BK
Pediatr Nephrol; 2016 Apr; 31(4):623-31. PubMed ID: 26525196
[TBL] [Abstract][Full Text] [Related]
6. YKL-40 levels are independently associated with albuminuria in type 2 diabetes.
Røndbjerg AK; Omerovic E; Vestergaard H
Cardiovasc Diabetol; 2011 Jun; 10():54. PubMed ID: 21696606
[TBL] [Abstract][Full Text] [Related]
7. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
8. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor and podocin predict nephropathy progression in type 2 diabetic patients through interaction with the autophagy influencer ULK-1.
El-Shazly AAA; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
J Diabetes Complications; 2019 Feb; 33(2):128-133. PubMed ID: 30545560
[TBL] [Abstract][Full Text] [Related]
10. Association of A1538G and C2437T single nucleotide polymorphisms in heat shock protein-70 genes with diabetic nephropathy among South Indian population.
Dhamodharan U; Ezhilarasi K; Ponjayanthi B; Sireesh D; Ramkumar KM; Viswanathan V
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28246355
[TBL] [Abstract][Full Text] [Related]
11. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population.
Aguilera E; Serra-Planas E; Granada ML; Pellitero S; Reverter JL; Alonso N; Soldevila B; Mauricio D; Puig-Domingo M
Cardiovasc Diabetol; 2015 Sep; 14():121. PubMed ID: 26382922
[TBL] [Abstract][Full Text] [Related]
12. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
[TBL] [Abstract][Full Text] [Related]
13. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
14. High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.
Lopes-Virella MF; Hunt KJ; Baker NL; Virella G;
J Diabetes Complications; 2016; 30(4):693-9. PubMed ID: 26861948
[TBL] [Abstract][Full Text] [Related]
15. Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy.
Abdel-Tawab MS; Mohamed MG; Doudar NA; Rateb EE; Reyad HR; Elazeem NAA
Mol Biol Rep; 2023 Dec; 50(12):9793-9803. PubMed ID: 37831346
[TBL] [Abstract][Full Text] [Related]
16. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
17. Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2.
Żurawska-Płaksej E; Ługowska A; Hetmańczyk K; Knapik-Kordecka M; Adamiec R; Piwowar A
Biomarkers; 2015 Feb; 20(1):52-7. PubMed ID: 25519006
[TBL] [Abstract][Full Text] [Related]
18. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy.
Sulaj A; Kopf S; Gröne E; Gröne HJ; Hoffmann S; Schleicher E; Häring HU; Schwenger V; Herzig S; Fleming T; Nawroth PP; von Bauer R
J Diabetes Complications; 2017 Jun; 31(6):1058-1065. PubMed ID: 28325697
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
[TBL] [Abstract][Full Text] [Related]
20. Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy.
Ma X; An L; Wang Q
Endocr Metab Immune Disord Drug Targets; 2017; 17(2):114-124. PubMed ID: 28699485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
